Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Inogen (INGN) Shares Outstanding (2016 - 2026)

Inogen has reported Shares Outstanding over the past 14 years, most recently at $27.2 million for Q4 2025.

  • Quarterly Shares Outstanding rose 13.93% to $27.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.2 million through Dec 2025, up 13.93% year-over-year, with the annual reading at $27.2 million for FY2025, 13.93% up from the prior year.
  • Shares Outstanding was $27.2 million for Q4 2025 at Inogen, roughly flat from $27.1 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $27.2 million in Q4 2025 and troughed at $22.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $23.3 million (2023), against an average of $23.9 million.
  • Year-over-year, Shares Outstanding grew 0.87% in 2022 and then rose 14.19% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $22.7 million in 2021, then increased by 0.92% to $22.9 million in 2022, then rose by 1.67% to $23.3 million in 2023, then rose by 2.48% to $23.9 million in 2024, then grew by 13.93% to $27.2 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's Shares Outstanding are $27.2 million (Q4 2025), $27.1 million (Q3 2025), and $27.0 million (Q2 2025).